Preferences
Related Series
Related Segments
Value-Based Care Reimbursement 2022
Organizations Anticipate Increased Revenue from VBC
Value-based care (VBC) has been established as a priority among healthcare organizations and payers as participants have gained more experience in managing their quality metrics and contracts, ultimately realizing returns on their investments. For this report, KLAS talked to 54 healthcare executives—including CEOs, CFOs, CIOs, CMIOs, COOs, VPs and directors of population health, and VPs of analytics—to gauge how they are moving beyond pay-for-performance into risk-bearing contracts over the next three years and their perceptions on which vendors can help them achieve their upcoming goals with VBC.
Significant Growth Anticipated for Medicaid and Capitation Contracts
Most respondents report strategic plans to expand their VBC contracts over the next three years. Participation in commercial plans, Medicare Advantage, and Medicare Shared Savings Programs will continue to be high, while Medicaid plans—which have the potential to impact a significant number of lives—will see the biggest growth. The administration of capitation contracts can be challenging for those who don’t have experience with them, but they are growing in appeal, as they allow for more predictable revenue than traditional fee-for-service models do.
“Capitation is the first realistic option that will allow us to move away from a fee-for-service model so that we can use our resources to really help patients. It will also allow us to decrease our costs without trying to charge for services. Capitation is probably our best option for breaking our broken model.” —CIO
“We will stay in all of our contracts so far as I can predict, but the only one we might consider entering into is Medicaid. We have talked about different care models with Medicaid. The issue is simply a matter of numbers.” —CMIO
Percent of Revenue Tied to VBC Varies Widely
VBC is making headway, but the depth of its adoption varies across organizations. Some hospitals are just starting out and have little to no revenue from VBC contracts. On the other hand, ACOs and clinically integrated networks, among others, may receive most or all of their revenue from value-based reimbursement, and they represent all organizations in this sample with over 90% of their revenue tied to VBC. Nationally, the average percentage of revenue tied to VBC contracts is about 10%. Even among this report’s sample, which is composed mostly of more progressive organizations, 50% receive one-fifth or less of their revenue from value-based reimbursement.
Respondents Overwhelmingly Expect to Bring in More Revenue from VBC in the Future
A vast majority of respondents anticipate that a larger percentage of their revenue will be tied to VBC three years from now. Key drivers of that expectation are newly available opportunities for VBC contracts and market pressures from payers and the government as they move the industry in the direction of VBC.
“There will be more revenue tied to value-based contracts in the future because of the expansion to more Medicaid, the potential expansion into another area, and our geographic focus on our value-based footprint. I do see us expanding out potentially in other areas.” —Director of population health
“It is getting more and more difficult to continue to ask for increases in rates. I negotiate rates with all the payers, and we are looking for alternatives in order to get involved with the total healthcare dollar. We are trying to develop efficiencies where there may be revenue opportunities. Those developments are what are pushing VBC revenue. As we think about how we integrate and develop better trust with payers, we are going to have to get more involved with shared savings arrangements.” —Senior VP
Provider Organizations Are Consolidating Their VBC Vendors
Overall, provider organizations are reducing the number of technology vendors or services firms they use to support VBC.† Only 20% of respondents use more than two vendors to help them tackle VBC; wanting a one-stop shop for data aggregation, analytics, and reporting, the majority have consolidated to either one or two.
† Technology consolidation is also a broader trend across the healthcare technology landscape. For more information, see a recent Bain & Company report written in collaboration with KLAS.
Epic Customers See Need for Multiple Vendors
Customers of Epic’s widely used Healthy Planet platform tend to be large, complex organizations and are a notable exception to the trend of consolidation seen with other VBC vendors. Citing the need for more robust data aggregation from outside systems and stronger analytics, dashboards, and care management tools, almost all Epic respondents use another solution to complement their use of Healthy Planet.
Epic, Arcadia, and Innovaccer Seen as Most Able to Assist Organizations with Future VBC Needs
Epic’s broad customer base feels that the vendor will be able to assist them with their future VBC needs due to improvements Epic is making to Healthy Planet. Respondents also acknowledge the advantage of Healthy Planet being in the providers’ day-to-day workflow, as it is integrated with the main Epic medical record. Respondents note that Arcadia will be able to provide for future needs because they offer a full suite of products, including robust data aggregation, reporting, and AI coding capabilities. Additionally, respondents highlight Arcadia’s ability to close quality gaps and view both clinical and financial data in one report. Likewise, respondents highlight Innovaccer as a vendor that will be able to assist with VBC in the future because of their impressive dashboards and predictive analytics. Additionally, Innovaccer is reportedly willing to build customized solutions to meet customers’ unique needs.
“Epic’s tool is integrated with our EMR, and we have implemented Epic’s systems across all platforms of care. That is why Epic is important.” —VP of population health
“We really feel like Innovaccer stands out among many of the other vendors we have looked at, so Innovaccer has the solution that can help us move forward in contracts as we learn and better understand the data that is coming in through the tool.” —Director
“If we decide we want to link more robust executive dashboards to track our performance with value-based care as we get bigger and we need better dashboards than what we can get from Epic or our current vendor, we may need the product. We are fine now, but as we grow, we may need better dashboards. I have seen Arcadia’s executive tracking dashboards, and they look phenomenal. The product would be a replacement. I would use Arcadia’s predictive analytics as well because they are as good as, if not better than, what we have.” —VP of population health
About This Report
This report is a perception study designed to help readers understand where the VBC market is currently and where it may be in the next three years. To gather these perspectives, KLAS spoke to 54 executives—including CEOs, CFOs, CIOs, CMIOs, COOs, VPs, and directors from areas of population health, finance, strategy, operations, and more. These executives were from 51 organizations across the US including health systems, clinically integrated networks, ACOs, and other risk-bearing entities. Interviews were conducted from February to August 2022.
The questions asked in the evaluation for this report are as follows:
- Which vendors are you using to support you in your VBC initiatives?
- What types of VBC contracts are you currently in?
- Thinking about the next three years or so, do you plan to stay in all of those contracts, are there ones you are planning on entering into, or are there ones that you are planning on leaving entirely?
- About how much of your current revenue is tied to VBC?
- Looking out three years, would you expect more, the same, or less revenue to be tied to value-based contracts, and why?
- Thinking about vendors who work in the VBC area, which ones do you think can best support your efforts, and why?
Writer
Elizabeth Pew
Designer
Natalie Jamison
Project Manager
Robert Ellis
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.